NCT00652717已完成4 期
A Multicenter, Open Study To Evaluate The Efficacy Of Ezetimibe 10 Mg Added On Statin Therapy, In Reducing LDL Cholesterol To Target Levels In Patients After Acute Coronary Syndrome
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 280
- 主要终点
- LDL levels
研究概览
简要总结
Collecting local data, safety and experience trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients; Post Acute Coronary Syndrome
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
arm 1 - Ezetimibe 10 mg daily that was added on Statin Therapy (prescribed clinically suitable dose by the physician).
干预措施: Ezetimibe (Drug)
1
Experimental
arm 1 - Ezetimibe 10 mg daily that was added on Statin Therapy (prescribed clinically suitable dose by the physician).
干预措施: simvastatin (Drug)
2
Active Comparator
arm 2- simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.
干预措施: simvastatin (Drug)
结局指标
主要结局
LDL levels
时间窗: 42 Days
次要结局
- Total cholesterol levels.(42 Days)
- Safety measures(42 days)
研究者
相似试验
已完成
4 期
Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)Attention Deficit Hyperactivity DisorderNCT00783835Janssen-Cilag Farmaceutica Ltda.60
已完成
4 期
Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAEHereditary AngioedemaNCT01457430Massachusetts General Hospital19
已完成
3 期
An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local EnvironmentRheumatoid ArthritisNCT01254331Hoffmann-La Roche51
已完成
4 期
Predicting Response to Standardized Pediatric Colitis TherapyUlcerative ColitisNCT01536535Connecticut Children's Medical Center431
已完成
3 期
EASSI - Evaluation of the Safety of Self-Administration With IcatibantHereditary AngioedemaNCT00997204Shire151